DE60131177D1 - Abbaubare polyacetal-polymere - Google Patents
Abbaubare polyacetal-polymereInfo
- Publication number
- DE60131177D1 DE60131177D1 DE60131177T DE60131177T DE60131177D1 DE 60131177 D1 DE60131177 D1 DE 60131177D1 DE 60131177 T DE60131177 T DE 60131177T DE 60131177 T DE60131177 T DE 60131177T DE 60131177 D1 DE60131177 D1 DE 60131177D1
- Authority
- DE
- Germany
- Prior art keywords
- polymers
- polyacetal polymers
- developable
- degradable polyacetal
- favorable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920000642 polymer Polymers 0.000 title abstract 5
- 229930182556 Polyacetal Natural products 0.000 title abstract 4
- 229920006324 polyoxymethylene Polymers 0.000 title abstract 4
- 230000002349 favourable effect Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2/00—Addition polymers of aldehydes or cyclic oligomers thereof or of ketones; Addition copolymers thereof with less than 50 molar percent of other substances
- C08G2/30—Chemical modification by after-treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G4/00—Condensation polymers of aldehydes or ketones with polyalcohols; Addition polymers of heterocyclic oxygen compounds containing in the ring at least once the grouping —O—C—O—
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L59/00—Compositions of polyacetals; Compositions of derivatives of polyacetals
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23037700P | 2000-09-06 | 2000-09-06 | |
| US230377P | 2000-09-06 | ||
| PCT/US2001/027664 WO2002020663A2 (en) | 2000-09-06 | 2001-09-06 | Degradable polyacetal polymers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60131177D1 true DE60131177D1 (de) | 2007-12-13 |
| DE60131177T2 DE60131177T2 (de) | 2008-08-07 |
Family
ID=22864985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60131177T Expired - Fee Related DE60131177T2 (de) | 2000-09-06 | 2001-09-06 | Abbaubare polyacetal-polymere |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7220414B2 (de) |
| EP (1) | EP1315777B1 (de) |
| AT (1) | ATE377048T1 (de) |
| AU (1) | AU2001288829A1 (de) |
| CA (1) | CA2453050A1 (de) |
| DE (1) | DE60131177T2 (de) |
| ES (1) | ES2294026T3 (de) |
| WO (1) | WO2002020663A2 (de) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8106098B2 (en) * | 1999-08-09 | 2012-01-31 | The General Hospital Corporation | Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
| CA2453050A1 (en) * | 2000-09-06 | 2002-03-14 | A.P. Pharma, Inc. | Degradable polyacetal polymers |
| US6590059B2 (en) | 2001-05-11 | 2003-07-08 | Ap Pharma, Inc. | Bioerodible polyorthoesters from dioxolane-based diketene acetals |
| CA2450949C (en) * | 2001-06-28 | 2009-04-28 | John Samuel | Methods and compositions for polyene antibiotics with reduced toxicity |
| DE60323936D1 (de) * | 2002-01-14 | 2008-11-20 | Gen Hospital Corp | Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung |
| US20040005351A1 (en) * | 2002-03-29 | 2004-01-08 | Kwon Glen S. | Polymeric micelle formulations of hydrophobic compounds and methods |
| CA2492803C (en) * | 2002-07-19 | 2013-11-05 | The General Hospital Corporation | Oxime conjugates and methods for their formation and use |
| AU2003256613A1 (en) * | 2002-07-19 | 2004-02-09 | Amgen Inc. | Protein conjugates with a water-soluble biocompatible, biogradable polymer |
| US7045589B2 (en) | 2002-11-15 | 2006-05-16 | A.P. Pharma, Inc. | Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| US6878374B2 (en) | 2003-02-25 | 2005-04-12 | Nitto Denko Corporation | Biodegradable polyacetals |
| US7332477B2 (en) * | 2003-07-10 | 2008-02-19 | Nitto Denko Corporation | Photocleavable DNA transfer agent |
| US7048925B2 (en) | 2003-08-28 | 2006-05-23 | Nitto Denko Corporation | Acid-sensitive polyacetals and methods |
| ATE507845T1 (de) * | 2003-09-05 | 2011-05-15 | Gen Hospital Corp | Polyacetal-arzneimittelkonjugate als freisetzungssystem |
| EP1667732B1 (de) | 2003-09-29 | 2010-04-21 | Nitto Denko Corporation | Biologisch abbaubare polyacetale für die in-vivo-abgabe von polynucleotiden |
| EP1682161A4 (de) * | 2003-10-29 | 2011-12-07 | Gentis Inc | Polymerisierbare emulsionen für die gewebeherstellung |
| GB0329654D0 (en) * | 2003-12-23 | 2004-01-28 | Smith & Nephew | Tunable segmented polyacetal |
| US7446099B2 (en) | 2004-02-27 | 2008-11-04 | Nitto Denko Corporation | Compositions and methods for biodegradable polymer-peptide mediated transfection |
| DE102004023117A1 (de) * | 2004-05-11 | 2005-12-08 | A. u. K. Müller GmbH & Co KG | Elektromagnetventil für flüssige Medien, insbesondere Heißwasser |
| US7358223B2 (en) * | 2004-10-04 | 2008-04-15 | Nitto Denko Corporation | Biodegradable cationic polymers |
| DE602005025676D1 (de) * | 2004-10-18 | 2011-02-10 | Nitto Denko Corp | Intrazelluläre peptidabgabe |
| US7674452B2 (en) * | 2005-03-16 | 2010-03-09 | Nitto Denko Corporation | Polymer coating of cells |
| AU2006230201A1 (en) * | 2005-03-31 | 2006-10-05 | A.P. Pharma, Inc. | PEG-polyacetal diblock and triblock copolymers and pharmaceutical compositions |
| CN101155844A (zh) * | 2005-03-31 | 2008-04-02 | 阿帕医药有限公司 | 聚乙二醇-聚缩醛和聚乙二醇-聚缩醛-聚原酸酯接枝共聚物和药物组合物 |
| US7456213B2 (en) * | 2005-03-31 | 2008-11-25 | A.P. Pharma, Inc. | PEG-poly(ortho ester) graft copolymers and pharmaceutical compositions |
| US7588754B2 (en) * | 2005-05-10 | 2009-09-15 | Nitto Denko Corporation | Biodegradable polyacetals and methods |
| US20060263328A1 (en) * | 2005-05-19 | 2006-11-23 | Sang Van | Hydrophilic polymers with pendant functional groups and method thereof |
| CA2619571A1 (en) * | 2005-08-18 | 2007-02-22 | Smith & Nephew, Plc | High strength devices and composites |
| JP2009511092A (ja) * | 2005-08-18 | 2009-03-19 | スミス アンド ネフュー ピーエルシー | マルチモーダル高強度デバイス及び複合材料 |
| US7700541B2 (en) * | 2006-04-06 | 2010-04-20 | Nitto Denko Corporation | Biodegradable cationic polymers |
| CN101594831B (zh) | 2006-11-30 | 2011-09-14 | 史密夫和内修有限公司 | 纤维增强的复合材料 |
| US8318795B2 (en) * | 2007-03-01 | 2012-11-27 | Cedars-Sinai Medical Center | Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof |
| JP5416090B2 (ja) | 2007-04-18 | 2014-02-12 | スミス アンド ネフュー ピーエルシー | 形状記憶ポリマーの膨張成形 |
| EP2142227B1 (de) | 2007-04-19 | 2012-02-29 | Smith & Nephew, Inc. | Multimodale formgedächtnis-polymere |
| DE602008006181D1 (de) | 2007-04-19 | 2011-05-26 | Smith & Nephew Inc | Graft-fixierung |
| US8658148B2 (en) | 2007-06-22 | 2014-02-25 | Genzyme Corporation | Chemically modified dendrimers |
| WO2009086547A1 (en) * | 2008-01-03 | 2009-07-09 | Cedars-Sinai Medical Center | Antioxidant nanosphere comprising [1,2]-dithiolane moieties |
| US8603531B2 (en) * | 2008-06-02 | 2013-12-10 | Cedars-Sinai Medical Center | Nanometer-sized prodrugs of NSAIDs |
| KR101493125B1 (ko) | 2008-11-24 | 2015-02-12 | 세다르스-신나이 메디칼 센터 | 항산화성 캠토테신 유도체 및 이들의 항산화성 항종양성 나노구체 |
| CL2009002167A1 (es) * | 2008-12-10 | 2010-10-15 | Mersana Therapeutics Inc | Formulacion farmaceutica para administracion endovenosa que comprende un compuesto derivado de conjugados de camptotecina-polimero biocompatibles y biodegradables, un agente de estabilizacion, uno o varios tampones y un tensoactivo, util para el tratamiento del cancer. |
| US8347887B2 (en) | 2008-12-23 | 2013-01-08 | Ams Research Corporation | Devices and methods for reversal of permanent sterilization |
| WO2012129070A2 (en) | 2011-03-24 | 2012-09-27 | Unversity Of Florida Research Foundation, Inc. | Acetal metathesis polymerization |
| EP2508544A1 (de) * | 2011-04-04 | 2012-10-10 | Argon Pharma S.L. | Abbaubare Polyacatylpolymere |
| JP5926374B2 (ja) | 2011-06-10 | 2016-05-25 | メルサナ セラピューティクス，インコーポレイティド | タンパク質−高分子−薬剤コンジュゲート |
| US8815226B2 (en) | 2011-06-10 | 2014-08-26 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| US20140017265A1 (en) * | 2012-07-05 | 2014-01-16 | Mersana Therapeutics, Inc. | Terminally Modified Polymers and Conjugates Thereof |
| CN105813655B (zh) | 2013-10-11 | 2022-03-15 | 阿萨纳生物科技有限责任公司 | 蛋白-聚合物-药物缀合物 |
| ES2726850T3 (es) | 2013-10-11 | 2019-10-09 | Mersana Therapeutics Inc | Conjugados de proteína-polímero-fármaco |
| WO2016090103A1 (en) | 2014-12-04 | 2016-06-09 | The Trustees Of Columbia University In The City Of New York | Biodegradable thermo-responsive polymers and uses thereof |
| WO2017189953A1 (en) | 2016-04-29 | 2017-11-02 | Children's Medical Center Corporation | Poly(ketals) and related compositions and methods |
Family Cites Families (134)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US77295A (en) * | 1868-04-28 | theqdoee krausch | ||
| US322392A (en) * | 1885-07-14 | Telepher | ||
| US19446A (en) * | 1858-02-23 | Money in cars | ||
| US159A (en) * | 1837-03-31 | John swainson | ||
| US64050A (en) * | 1867-04-23 | Samuel jacob wallace | ||
| US115734A (en) * | 1871-06-06 | Improvement in brick-kilns | ||
| US30444A (en) * | 1860-10-16 | william dopp | ||
| US471036A (en) * | 1892-03-15 | Feeding mechanism for sewing-machines | ||
| US90398A (en) * | 1869-05-25 | Improvement in tree-boxes | ||
| US174411A (en) * | 1876-03-07 | Improvement in lamp-lighting devices | ||
| US138474A (en) * | 1873-05-06 | Improvement in wave-powers | ||
| US135929A (en) * | 1873-02-18 | Improvement in the manufacture of car-springs | ||
| US37300A (en) * | 1863-01-06 | Improvement in window-blind fastenings | ||
| US419156A (en) * | 1890-01-07 | mcgiehan | ||
| US54863A (en) * | 1866-05-22 | coghkan | ||
| US291668A (en) * | 1884-01-08 | Self-closing faucet | ||
| US152630A (en) * | 1874-06-30 | Improvement in cars for transporting coal | ||
| US176844A (en) * | 1876-05-02 | Improvement in beer-taps | ||
| US466566A (en) * | 1892-01-05 | jenny | ||
| US151668A (en) * | 1874-06-02 | Improvement in machines for cutting paper | ||
| US1482663A (en) * | 1922-01-12 | 1924-02-05 | Frederic A Shouldice | Stone gatherer |
| US1579490A (en) * | 1924-10-16 | 1926-04-06 | Ke Haw Ke Mfg Company | Tube-vulcanizing device |
| US2238477A (en) * | 1940-01-06 | 1941-04-15 | George E Murber | Golf rubber overshoe |
| US2352547A (en) * | 1941-12-19 | 1944-06-27 | Pittsburgh Plate Glass Co | ?fining of tall oil |
| US3268550A (en) | 1963-08-26 | 1966-08-23 | Ibm | Nu-butenyl carbazoles |
| US4180064A (en) | 1972-12-27 | 1979-12-25 | Alza Corporation | System for delivering agent to environment of use over prolonged time |
| US4014987A (en) * | 1974-06-04 | 1977-03-29 | Alza Corporation | Device for delivery of useful agent |
| US4131648A (en) | 1975-01-28 | 1978-12-26 | Alza Corporation | Structured orthoester and orthocarbonate drug delivery devices |
| US4180646A (en) | 1975-01-28 | 1979-12-25 | Alza Corporation | Novel orthoester polymers and orthocarbonate polymers |
| US4093709A (en) * | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
| US4079038A (en) * | 1976-03-05 | 1978-03-14 | Alza Corporation | Poly(carbonates) |
| US4152547A (en) * | 1977-11-29 | 1979-05-01 | Theis Peter F | Selective monitor for an automatic telephone answering system |
| US4131662A (en) | 1978-01-03 | 1978-12-26 | Mobay Chemical Corporation | Talc-based external mold release agent for polyurethane foams |
| US4261969A (en) * | 1979-05-03 | 1981-04-14 | World Health Organization | Controlled drug release composition |
| US4249531A (en) * | 1979-07-05 | 1981-02-10 | Alza Corporation | Bioerodible system for delivering drug manufactured from poly(carboxylic acid) |
| US4304767A (en) | 1980-05-15 | 1981-12-08 | Sri International | Polymers of di- (and higher functionality) ketene acetals and polyols |
| US4502976A (en) * | 1982-10-25 | 1985-03-05 | Bend Research, Inc. | Water soluble polyesters |
| US4513143A (en) * | 1982-12-01 | 1985-04-23 | Sri International | Preparation of ketene acetals |
| US4690682A (en) | 1983-04-15 | 1987-09-01 | Damon Biotech, Inc. | Sustained release |
| US5449670A (en) | 1983-05-20 | 1995-09-12 | Skinner; Wilfred A. | Composition and method for the transdermal delivery of bioactive peptides |
| US4710497A (en) | 1983-05-20 | 1987-12-01 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering physiologically active agents |
| US4590190A (en) * | 1983-07-01 | 1986-05-20 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
| US4752612A (en) * | 1983-07-01 | 1988-06-21 | Nitto Electrical Industrial Co., Ltd. | Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent |
| US5128376A (en) * | 1983-07-01 | 1992-07-07 | Nitto Denko Corporation | Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator |
| US4548990A (en) | 1983-08-15 | 1985-10-22 | Ciba-Geigy Corporation | Crosslinked, porous polymers for controlled drug delivery |
| US4818542A (en) * | 1983-11-14 | 1989-04-04 | The University Of Kentucky Research Foundation | Porous microspheres for drug delivery and methods for making same |
| US4605670A (en) | 1984-02-01 | 1986-08-12 | Nitto Electric Industrial Co., Ltd. | Method for percutaneously administering metoclopramide |
| US4765973A (en) * | 1984-06-06 | 1988-08-23 | Merck & Co., Inc. | Polymers containing pendant acid functionalities and labile backbone bonds |
| US4639366A (en) * | 1984-06-06 | 1987-01-27 | Merck & Co., Inc. | Polymers containing pendant acid functionalities and labile backbone bonds |
| GB8416234D0 (en) * | 1984-06-26 | 1984-08-01 | Ici Plc | Biodegradable amphipathic copolymers |
| US4549010A (en) | 1984-06-27 | 1985-10-22 | Merck & Co., Inc. | Bioerodible poly(ortho ester) thermoplastic elastomer from diketene diacetal |
| GB8500209D0 (en) | 1985-01-04 | 1985-02-13 | Ceskoslovenska Akademie Ved | Synthetic polymeric drugs |
| US4690825A (en) | 1985-10-04 | 1987-09-01 | Advanced Polymer Systems, Inc. | Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen |
| US4855132A (en) | 1986-02-25 | 1989-08-08 | S R I International | Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product |
| US4764364A (en) | 1986-02-25 | 1988-08-16 | S R I International | Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product |
| US4801457A (en) * | 1986-08-01 | 1989-01-31 | Sandoz Pharm. Corp. | Polyacetal hydrogels formed from divinyl ethers and polyols |
| US4713441A (en) * | 1986-08-01 | 1987-12-15 | Sandoz Pharmaceuticals Corp. | Polyacetal hydrogels formed from divinyl ethers and polyols |
| US4849426A (en) * | 1987-05-15 | 1989-07-18 | Pearlman Dale L | Method for treating actinic keratosis with cytotoxic agents |
| US5013553A (en) * | 1987-06-30 | 1991-05-07 | Vipont Pharmaceutical, Inc. | Drug delivery devices |
| US5080891A (en) | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
| US4923645A (en) * | 1987-11-16 | 1990-05-08 | Damon Biotech, Inc. | Sustained release of encapsulated molecules |
| US4898928A (en) * | 1988-03-07 | 1990-02-06 | Sandoz Pharmaceuticals Corp. | Polyacetal and polyketal hydrogels formed from acetals or ketals and polyols |
| US4957998A (en) | 1988-08-22 | 1990-09-18 | Pharmaceutical Delivery Systems, Inc. | Polymers containing acetal, carboxy-acetal, ortho ester and carboxyortho ester linkages |
| US5702716A (en) | 1988-10-03 | 1997-12-30 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
| US5725491A (en) * | 1988-10-03 | 1998-03-10 | Atrix Laboratories, Inc. | Method of forming a biodegradable film dressing on tissue |
| US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5632727A (en) * | 1988-10-03 | 1997-05-27 | Atrix Laboratories, Inc. | Biodegradable film dressing and method for its formation |
| US5324520A (en) * | 1988-12-19 | 1994-06-28 | Vipont Pharmaceutical, Inc. | Intragingival delivery systems for treatment of periodontal disease |
| US4963369A (en) | 1989-01-19 | 1990-10-16 | Wm. Wrigley Jr. Co. | Gum composition containing dispersed porous beads containing active chewing gum ingredients and method |
| US5108755A (en) * | 1989-04-27 | 1992-04-28 | Sri International | Biodegradable composites for internal medical use |
| DE69024953T3 (de) * | 1989-05-04 | 2005-01-27 | Southern Research Institute, Birmingham | Einkapselungsverfahren |
| US5028435A (en) * | 1989-05-22 | 1991-07-02 | Advanced Polymer Systems, Inc. | System and method for transdermal drug delivery |
| US4946931A (en) | 1989-06-14 | 1990-08-07 | Pharmaceutical Delivery Systems, Inc. | Polymers containing carboxy-ortho ester and ortho ester linkages |
| US5013821A (en) * | 1989-06-15 | 1991-05-07 | Pharmaceutical Delivery Systems, Inc. | Ortho and thio-ortho ester polymer |
| US5324519A (en) * | 1989-07-24 | 1994-06-28 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
| US5487897A (en) * | 1989-07-24 | 1996-01-30 | Atrix Laboratories, Inc. | Biodegradable implant precursor |
| US5077049A (en) | 1989-07-24 | 1991-12-31 | Vipont Pharmaceutical, Inc. | Biodegradable system for regenerating the periodontium |
| US5030457A (en) * | 1989-08-28 | 1991-07-09 | Pharmaceutical Delivery Systems, Inc. | Bioerodible polymers useful for the controlled release of therapeutic agents |
| JPH05502465A (ja) | 1989-08-28 | 1993-04-28 | ファーマスーティカル デリバリー システムズ | 治療薬剤の制御放出のために有用な生体内で分解し得るポリマー |
| US5047464A (en) | 1989-09-20 | 1991-09-10 | Merck & Co., Inc. | Bioerodible thermoset elastomers |
| US5217712A (en) | 1989-09-20 | 1993-06-08 | Merck & Co., Inc. | Bioerodible thermoset elastomers |
| IL98087A (en) * | 1990-05-04 | 1996-11-14 | Perio Prod Ltd | Preparation for dispensing drugs in the colon |
| US5587507A (en) * | 1995-03-31 | 1996-12-24 | Rutgers, The State University | Synthesis of tyrosine derived diphenol monomers |
| SE9002339L (sv) * | 1990-07-04 | 1992-01-05 | Kabi Pharmacia Ab | Terapeutisk komposition och foerfarande foer dess framstaellning |
| NZ239370A (en) | 1990-08-22 | 1994-04-27 | Merck & Co Inc | Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone |
| AU8935591A (en) * | 1990-10-30 | 1992-05-26 | Alza Corporation | Drug delivery system and method |
| US5422121A (en) * | 1990-11-14 | 1995-06-06 | Rohm Gmbh | Oral dosage unit form |
| HU222501B1 (hu) * | 1991-06-28 | 2003-07-28 | Endorecherche Inc. | MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására |
| US5211951A (en) * | 1991-07-24 | 1993-05-18 | Merck & Co., Inc. | Process for the manufacture of bioerodible poly (orthoester)s and polyacetals |
| AU2605592A (en) | 1991-10-15 | 1993-04-22 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
| EP0560014A1 (de) | 1992-03-12 | 1993-09-15 | Atrix Laboratories, Inc. | Biologisch abbaubarer Wundverband in Form eines Sprühfilms und Verfahren zu seiner Herstellung |
| AU3941493A (en) * | 1992-03-30 | 1993-11-08 | Alza Corporation | Viscous suspensions of controlled-release drug particles |
| US5334640A (en) | 1992-04-08 | 1994-08-02 | Clover Consolidated, Ltd. | Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods |
| US5461140A (en) | 1992-04-30 | 1995-10-24 | Pharmaceutical Delivery Systems | Bioerodible polymers for solid controlled release pharmaceutical compositions |
| JPH07507804A (ja) * | 1992-06-09 | 1995-08-31 | ネオルックス コーポレーション | 予備標的化方法及び化合物 |
| GB9217331D0 (en) | 1992-08-14 | 1992-09-30 | Xenova Ltd | Pharmaceutical compounds |
| GB2270920B (en) * | 1992-09-25 | 1997-04-02 | Univ Keele | Alginate-bioactive agent conjugates |
| MY113268A (en) * | 1992-12-29 | 2002-01-31 | Insite Vision Incorporated | Plasticized bioerodible controlled delivery system |
| GB2282384B8 (en) * | 1993-08-18 | 1997-09-04 | Europ Economic Community | Drug delivery agents incorporating mitomycin |
| IL110787A0 (en) * | 1993-08-27 | 1994-11-11 | Sandoz Ag | Biodegradable polymer, its preparation and pharmaceutical composition containing it |
| US5681873A (en) | 1993-10-14 | 1997-10-28 | Atrix Laboratories, Inc. | Biodegradable polymeric composition |
| EP0734371B1 (de) * | 1993-12-15 | 2000-04-05 | Avon Products, Inc. | Neue retinoidkonjugate zur behandlung von alterserscheinungen der haut |
| IL112627A0 (en) * | 1994-02-14 | 1995-05-26 | Xenova Ltd | Diketopiperazines, their preparation and pharmaceutical or veterinary compositions containing them |
| GB9402805D0 (en) * | 1994-02-14 | 1994-04-06 | Xenova Ltd | Pharmaceutical compounds |
| GB9402809D0 (en) | 1994-02-14 | 1994-04-06 | Xenova Ltd | Pharmaceutical compounds |
| JP4259610B2 (ja) * | 1994-04-08 | 2009-04-30 | キューエルティー・ユーエスエイ・インコーポレーテッド | 液体デリバリー組成物 |
| US6007845A (en) | 1994-07-22 | 1999-12-28 | Massachusetts Institute Of Technology | Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| US5607686A (en) * | 1994-11-22 | 1997-03-04 | United States Surgical Corporation | Polymeric composition |
| GB9426090D0 (en) | 1994-12-23 | 1995-02-22 | Xenova Ltd | Pharmaceutical compounds |
| US5891877A (en) * | 1995-02-14 | 1999-04-06 | Xenova Limited | Pharmaceutical compounds |
| US5627187A (en) * | 1995-04-12 | 1997-05-06 | Katz; Bruce E. | 5-FU for treating actinic kerotoses |
| US5811510A (en) * | 1995-04-14 | 1998-09-22 | General Hospital Corporation | Biodegradable polyacetal polymers and methods for their formation and use |
| US6096344A (en) * | 1995-07-28 | 2000-08-01 | Advanced Polymer Systems, Inc. | Bioerodible porous compositions |
| US5877224A (en) * | 1995-07-28 | 1999-03-02 | Rutgers, The State University Of New Jersey | Polymeric drug formulations |
| AU710347B2 (en) * | 1995-08-31 | 1999-09-16 | Alkermes Controlled Therapeutics, Inc. | Composition for sustained release of an agent |
| US5968543A (en) | 1996-01-05 | 1999-10-19 | Advanced Polymer Systems, Inc. | Polymers with controlled physical state and bioerodibility |
| IL118235A0 (en) * | 1996-05-13 | 1996-09-12 | Univ Ben Gurion | Composition and method for forming biodegradable implants in situ and uses of these implants |
| US5993856A (en) | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
| US5965118A (en) | 1997-04-18 | 1999-10-12 | Access Pharmaceuticals, Inc. | Polymer-platinum compounds |
| AU7124598A (en) | 1997-04-18 | 1998-11-13 | Access Pharmaceuticals, Inc. | Polymer-platinum compounds |
| CN1259875A (zh) * | 1997-06-11 | 2000-07-12 | 伦敦大学药学院 | 含有与前体药物结合的抗体－酶偶联物的药物组合物 |
| DE69833487T9 (de) * | 1997-06-12 | 2007-03-01 | Innovata Plc, Ruddington | Polymer-wirkstoff-konjugate zur behandlung von krebs |
| US6585956B2 (en) * | 1997-07-07 | 2003-07-01 | The Dow Chemical Company | Dendritic-platinate drug delivery system |
| US6193991B1 (en) * | 1997-10-29 | 2001-02-27 | Atul J. Shukla | Biodegradable delivery systems of biologically active substances |
| US6048736A (en) * | 1998-04-29 | 2000-04-11 | Kosak; Kenneth M. | Cyclodextrin polymers for carrying and releasing drugs |
| US5939453A (en) | 1998-06-04 | 1999-08-17 | Advanced Polymer Systems, Inc. | PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers |
| US6245345B1 (en) * | 1998-07-07 | 2001-06-12 | Atrix Laboratories, Inc. | Filamentous porous films and methods for producing the same |
| US6261583B1 (en) * | 1998-07-28 | 2001-07-17 | Atrix Laboratories, Inc. | Moldable solid delivery system |
| US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| US6822086B1 (en) * | 1999-08-09 | 2004-11-23 | The General Hospital Corporation | Drug-carrier complexes and methods of use thereof |
| EP1142596A1 (de) * | 2000-04-03 | 2001-10-10 | Universiteit Gent | Zusammensetzung von vernetzbaren Prepolymeren zum Gebrauch in therapeutisch aktiven, bioabbaubaren Implantaten |
| CA2453050A1 (en) * | 2000-09-06 | 2002-03-14 | A.P. Pharma, Inc. | Degradable polyacetal polymers |
| US6590059B2 (en) * | 2001-05-11 | 2003-07-08 | Ap Pharma, Inc. | Bioerodible polyorthoesters from dioxolane-based diketene acetals |
| US6524606B1 (en) * | 2001-11-16 | 2003-02-25 | Ap Pharma, Inc. | Bioerodible polyorthoesters containing amine groups |
-
2001
- 2001-09-06 CA CA002453050A patent/CA2453050A1/en not_active Abandoned
- 2001-09-06 DE DE60131177T patent/DE60131177T2/de not_active Expired - Fee Related
- 2001-09-06 EP EP01968589A patent/EP1315777B1/de not_active Expired - Lifetime
- 2001-09-06 WO PCT/US2001/027664 patent/WO2002020663A2/en active IP Right Grant
- 2001-09-06 AU AU2001288829A patent/AU2001288829A1/en not_active Abandoned
- 2001-09-06 US US09/949,162 patent/US7220414B2/en not_active Expired - Fee Related
- 2001-09-06 ES ES01968589T patent/ES2294026T3/es not_active Expired - Lifetime
- 2001-09-06 AT AT01968589T patent/ATE377048T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1315777B1 (de) | 2007-10-31 |
| WO2002020663A3 (en) | 2002-05-10 |
| US20020082362A1 (en) | 2002-06-27 |
| WO2002020663A2 (en) | 2002-03-14 |
| EP1315777A2 (de) | 2003-06-04 |
| US7220414B2 (en) | 2007-05-22 |
| ATE377048T1 (de) | 2007-11-15 |
| ES2294026T3 (es) | 2008-04-01 |
| AU2001288829A1 (en) | 2002-03-22 |
| DE60131177T2 (de) | 2008-08-07 |
| CA2453050A1 (en) | 2002-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60131177D1 (de) | Abbaubare polyacetal-polymere | |
| AU3468900A (en) | Cyclodextrin polymers for use as drug carriers | |
| TNSN03137A1 (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING LOW SOLUBILITY AND / OR ACID SENSITIVE DRUGS AND NEUTRALIZED ACID POLYMERS. | |
| ATE426635T1 (de) | Arzneimittelverabreichung | |
| MD20070267A (en) | Gastroresistant pharmaceutical formulation containing rifaximin | |
| MY129809A (en) | Quinazoline derivatives | |
| WO2000064486A3 (en) | Enzymatically activated polymeric drug conjugates | |
| BR0207378A (pt) | Tratamento de câncer | |
| AU6559800A (en) | Use of hyaluronic acid derivatives in pharmaceutical preparations and biomaterials for the prevention and treatment of cutaneous scars | |
| ES2249888T3 (es) | Conjugados de paclitaxel solubles en agua, combinados con irradiacion para el tratamiento del cancer. | |
| CY1105225T1 (el) | Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας | |
| MY127369A (en) | Quinazoline derivatives | |
| CY1108274T1 (el) | Μακροβιο ομοιαζον με γλυκογονο πεπτιδιο 2 (glp-2) για την θεραπεια γαστρεντερικων ασθενειων και διαταραχων | |
| ATE478840T1 (de) | 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung | |
| HK1071390A1 (en) | Ph responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery | |
| WO2001087227A3 (en) | Drug containing polymeric micelles | |
| BR0014378A (pt) | Derivados de ácido indolil-3-glioxìlico tendo propriedades terapeuticamente valiosas | |
| MXPA05006688A (es) | Conjugados de polimero con una variante de cianovirina. | |
| WO2004098564A3 (en) | Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide | |
| GB2451599A (en) | Nanostructures suitable for delivery of agents | |
| AUPQ879500A0 (en) | Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease | |
| EP2286826A3 (de) | Behandlung von Tumor-Metastasen und Krebs | |
| DE60113445D1 (de) | Substanzen mit verzweigten linkermolekülen | |
| ATE317703T1 (de) | Polymer-wirkstoff-konjugate zur behandlung von krebs | |
| BR0014372A (pt) | Derivados de 5-hidroxissapogenina com atividade antidemência |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |